BML Capital Management, LLC - MILESTONE PHARMACEUTICALS IN ownership

MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 57 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
BML Capital Management, LLC ownership history of MILESTONE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$844,750
+8.8%
272,5000.0%0.78%
+11.0%
Q2 2023$776,625
-10.4%
272,500
+23.9%
0.70%
-6.7%
Q1 2023$866,800
+21.6%
220,000
+22.2%
0.75%
+10.0%
Q4 2022$712,800180,0000.68%
Other shareholders
MILESTONE PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 1,928,752$12,383,0001.63%
ACUTA CAPITAL PARTNERS, LLC 380,000$2,440,0001.14%
Lion Point Capital, LP 683,570$4,388,0001.02%
Novo Holdings A/S 2,530,003$16,243,0000.86%
Boxer Capital, LLC 2,238,861$14,373,0000.74%
RTW INVESTMENTS, LP 4,315,102$27,703,0000.57%
RA Capital Management 2,246,503$14,423,0000.32%
Bleichroeder LP 250,000$1,605,0000.28%
Orbimed Advisors 2,583,821$16,588,0000.27%
PURA VIDA INVESTMENTS, LLC 987,411$6,339,0000.21%
View complete list of MILESTONE PHARMACEUTICALS IN shareholders